Cited by 34COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRenin-Angiotensin System Studies

COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?

Open access
Kutti Sridharan, Gurusaravanan, Kotagiri, Rajesh, Chandiramani, Vijay H., Mohan, Babu P., Vegunta, Rathnamitreyee, Vegunta, Radhakrishna, Rokkam, Venkata R. P.·2020·American Journal of Therapeutics

Abstract

Ibuprofen is an over-the-counter medication that is used widely for the treatment of pain and fever during COVID-19 pandemic. A concern was raised regarding the safety of ibuprofen use because of its role in increasing ACE2 levels within the Renin–Angiotensin–Aldosterone system. ACE2 is the coreceptor for the entry of SARS-CoV-2 into cells, and so, a potential increased risk of contracting COVID-19 disease and/or worsening of COVID-19 infection was feared with ibuprofen use. However, available data from limited studies show administration of recombinant ACE2 improves lung damage caused by respiratory viruses, suggesting ibuprofen use may be beneficial in COVID-19 disease. At this time, there is no supporting evidence to discourage the use of ibuprofen.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mjt.0000000000001196

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kutti Sridharan, G., Kotagiri, R., Chandiramani, V. H., Mohan, B. P., Vegunta, R., Vegunta, R., & Rokkam, V. R. P.
Affiliations
  • Department of Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ;
  • University of Arizona (US)
  • Sanford Health (US)
Venue
American Journal of Therapeutics
Published
2020-04-24
Volume
27
Issue
4
Pages
e400-e402
ISSN
1075-2765 (ISSN-L)
OpenAlex
W3022151458
Cited by
34
References
17
Citations by year
2024: 2 · 2023: 3 · 2022: 4 · 2021: 17 · 2020: 8
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • American Journal of Therapeutics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UA Campus Repository (The University of Arizona) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
ibuprofen, COVID-19 pandemic, SARS-CoV-2, ACE2, renin-angiotensin-aldosterone system, over-the-counter analgesics, drug safety, lung injury, respiratory viruses, evidence evaluation
MeSH terms
Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Angiotensin-Converting Enzyme Inhibitors, Animals, Anti-Inflammatory Agents, Non-Steroidal, Humans, Ibuprofen, Peptidyl-Dipeptidase A, Lung, Pneumonia, Viral, Receptors, Virus, Renin-Angiotensin System, Coronavirus Infections, Evidence-Based Medicine, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review